0000950123-23-010857.txt : 20231114
0000950123-23-010857.hdr.sgml : 20231114
20231114160018
ACCESSION NUMBER: 0000950123-23-010857
CONFORMED SUBMISSION TYPE: 13F-NT
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230930
FILED AS OF DATE: 20231114
DATE AS OF CHANGE: 20231114
EFFECTIVENESS DATE: 20231114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund III, L.P.
CENTRAL INDEX KEY: 0001875273
IRS NUMBER: 871342200
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-NT
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-22979
FILM NUMBER: 231405508
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON ST
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 16175162000
MAIL ADDRESS:
STREET 1: 200 CLARENDON ST
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-NT
1
primary_doc.xml
X0202
13F-NT
LIVE
0001875273
XXXXXXXX
09-30-2023
09-30-2023
false
Bain Capital Life Sciences Fund III, L.P.
200 Clarendon St
Boston
MA
02116
13F NOTICE
028-22979
28-18477
Bain Capital Life Sciences Investors, LLC
28-22975
Bain Capital Life Sciences III General Partner, LLC
Y
The report on Form 13F for the period ended September 30, 2023 for Bain Capital Life Sciences Fund III, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences III General Partner, LLC, which is the general partner of the Fund.
Adam Koppel
Partner of Bain Capital Life Sciences Investors, LLC
617-516-2000
/s/ Adam Koppel
Boston
MA
11-14-2023